Scientific and Medical Equipment House Company (4014.SR)
SAR 40.5
(1.0%)
SAR 40.5
(1.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 100.76 Million SAR | 68.05% |
| 2022 | 60.98 Million SAR | -50.69% |
| 2021 | 110.76 Million SAR | 2.57% |
| 2020 | 104.54 Million SAR | 4.81% |
| 2019 | 98.01 Million SAR | -4.24% |
| 2018 | 99.65 Million SAR | 34.07% |
| 2017 | 71.59 Million SAR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 19.86 Million SAR | -11.91% |
| 2024 Q1 | 23.8 Million SAR | -27.54% |
| 2023 Q3 | 33.66 Million SAR | 112.45% |
| 2023 FY | - SAR | 68.05% |
| 2023 Q4 | 13.23 Million SAR | -60.69% |
| 2023 Q1 | 19.22 Million SAR | 201.14% |
| 2023 Q2 | 15.84 Million SAR | -17.56% |
| 2022 Q4 | -19 Million SAR | -184.39% |
| 2022 FY | - SAR | -50.69% |
| 2022 Q2 | 29.06 Million SAR | 3.38% |
| 2022 Q1 | 28.11 Million SAR | 26.22% |
| 2022 Q3 | 22.52 Million SAR | -22.5% |
| 2021 Q2 | 32.53 Million SAR | 36.76% |
| 2021 Q1 | 23.78 Million SAR | 11.6% |
| 2021 FY | - SAR | 2.57% |
| 2021 Q4 | 22.27 Million SAR | -13.52% |
| 2021 Q3 | 25.75 Million SAR | -20.84% |
| 2020 Q2 | 25.25 Million SAR | -0.0% |
| 2020 Q1 | 25.25 Million SAR | 0.0% |
| 2020 FY | - SAR | 4.81% |
| 2020 Q4 | 21.31 Million SAR | 0.0% |
| 2020 Q3 | 21.31 Million SAR | -15.6% |
| 2019 FY | - SAR | -4.24% |
| 2018 FY | - SAR | 34.07% |
| 2017 FY | - SAR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|